The following represents disclosure information provided by authors of this abstract. The ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer Planning Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
DNA mismatch repair deficiency and benefit from adjuvant bevacizumab in NSABP C-08: Molecular profiling results.
Katherine L. Pogue-Geile
No relevant relationships to disclose
Noriko Tanaka
No relevant relationships to disclose
Patrick Gavin
No relevant relationships to disclose
Greg Yothers
Consultant or Advisory Role - Roche/Genentech
Linda H. Colangelo
No relevant relationships to disclose
Chungyeul Kim
No relevant relationships to disclose
Seong-Rim Kim
No relevant relationships to disclose
Debora Fumagalli
No relevant relationships to disclose
Yusuke Taniyama
No relevant relationships to disclose
Saima Sharif
No relevant relationships to disclose
Michael J. O'Connell
No relevant relationships to disclose
Soonmyung Paik
No relevant relationships to disclose